Response to bortezomib in newly diagnosed multiple myeloma- a single centre experience from India

被引:0
|
作者
Rajan, V. [1 ]
N, G. [1 ]
Nair, S. G. [1 ]
机构
[1] Reg Canc Ctr Thiruvananthapuram Trivandrum, Med Oncol, Thiruvananthapuram, Kerala, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
305P
引用
收藏
页码:90 / 90
页数:1
相关论文
共 50 条
  • [31] CYBORD IS AN ACTIVE, WELL TOLERATED, COST-EFFECTIVE INDUCTION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA - A SINGLE CENTRE EXPERIENCE
    Krawczyk, J.
    Khan, S.
    Ahsan, B.
    Eltom, S.
    Saeed, K. A.
    Gibbons, C.
    Maloney, K.
    Meenaghan, T.
    Walpole, G.
    Abdelrahmen, M.
    Hayat, A.
    Hodgson, A.
    Murray, M.
    O'Dwyer, M. E.
    [J]. HAEMATOLOGICA, 2014, 99 : 656 - 656
  • [32] Cybord Is An Active, Well Tolerated, Cost-Effective Induction Regimen In Newly Diagnosed Multiple Myeloma - a Single Centre Experience
    Krawczyk, Janusz
    Khan, Sahar
    Ahsan, Bushra
    Higgins, Larissa
    McGowan, Enda
    Eltom, Safa
    Saeed, Khalid Awad
    Gibbons, Carmelita
    Maloney, Karen
    Meenaghan, Teresa
    Walpole, Geraldine
    Collins, Catriona
    Snedker, Robert
    Abdelrahmen, Moutaz
    Hayat, Amjad
    Hodgson, Andrew
    Murray, Margaret
    O'Dwyer, Michael E.
    [J]. BLOOD, 2013, 122 (21)
  • [33] Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment
    Jian, Yuan
    Chang, Long
    Shi, Ming-Xia
    Sun, Ying
    Chu, Xiao-Xia
    Xue, Hua
    Huang, Wen-Rong
    Shen, Xu-Liang
    Ma, Jie
    Jia, Guo-Rong
    Feng, Ya-Qing
    Xi, Zhen-Fang
    Zhao, Yan-Hong
    Ma, Yan-Ping
    Xiao, Jing
    Ma, Guang-Yu
    Wang, Qing-Ming
    Bao, Li
    Dong, Yu-Jun
    Zhou, He-Bing
    Sun, Chun-Yan
    Su, Guo-Hong
    Yan, Yan
    Qimuge, Sai-Yin
    Su, Li-Ping
    Sun, Jing-Nan
    Tian, Wei-Wei
    Sun, Xiu-Li
    Ing, Hong-Mei
    Gao, Da
    Chen, Wen-Ming
    Li, Jian
    Gao, Wen
    [J]. BLOOD ADVANCES, 2023, 7 (24) : 7581 - 7584
  • [34] Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma
    Ghosh, Nilanjan
    Ye, Xiaobu
    Ferguson, Anna
    Huff, Carol Ann
    Borrello, Ivan
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 593 - 599
  • [35] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    [J]. BLOOD, 2010, 116 (05) : 679 - 686
  • [36] Bortezomib and Thalidomide, a Steroid Free Regimen in Newly Diagnosed Patients with Multiple Myeloma
    Ghosh, Nilanjan
    Ferguson, Anna
    Ye, Xiaobu
    Huff, Carol A.
    Borrello, Ivan M.
    [J]. BLOOD, 2009, 114 (22) : 1119 - 1119
  • [37] A 28 Day Schedule for Lenalidomide Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma
    Chari, Ajai
    Roper, Nitin
    Jagannath, Sundar
    [J]. BLOOD, 2011, 118 (21) : 1272 - 1273
  • [38] Subcutaneous Bortezomib, Melphalan and Prednisone in Elderly Newly Diagnosed Multiple Myeloma Patients
    Herbaux, Charles
    Joao, Cristina M.
    Plocque, Alexia
    Richez, Valentine
    Gay, Francesca
    Renaud, Loic
    Legros, Laurence
    Garderet, Laurent
    Ikhlef, Souhila
    Pegourie, Brigitte
    Escoffre-Barbe, Martine
    Royer, Bruno
    Voillat, Laurent
    Hulin, Cyrille
    Banos, Anne
    Voog, Eric G.
    Karlin, Lionel
    Stoppa, Anne-Marie
    Benboubker, Lotfi
    Zweegman, Sonja
    De Jongh, Eva
    Abildgaard, Niels
    Le Du, Katell
    Jurczyszyn, Artur J.
    Moreau, Philippe
    Facon, Thierry
    Caillot, Denis
    Terpos, Evangelos
    Leleu, Xavier
    [J]. BLOOD, 2014, 124 (21)
  • [39] Re-challenging myeloma patients with bortezomib: experience at a single centre
    Rabin, N
    Penny, F
    D'Sa, S
    Yong, K
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 60 - 60
  • [40] Myanmar Experience of Clinical Response of Patients With Newly Diagnosed Symptomatic Multiple Myeloma Treated with Bortezomib Based or Non-Bordezomib Based Therapy
    Linn, Swe Mar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E153 - E153